Effects of Wnt‑1 blockade in DEN‑induced hepatocellular adenomas of mice
- 15 November 2017
- journal article
- research article
- Published by Spandidos Publications in Oncology Letters
- Vol. 15 (1) , 1211-1219
Abstract
Recent evidence has suggested that downregulation of the Wnt/β‑catenin signaling pathway may contribute to the development and growth of HCC. Consequently, elements of this pathway have begun to emerge as potential targets for improving outcomes of anti‑HCC. Thus, the present study sought to examine the effects of Wnt‑1 blockade using the classical diethylnitrosamine (DEN)‑induced chemical carcinogenesis mouse model of HCC. The depletion of Wnt‑1 using neutralizing antisera was done for ten consecutive days at the age of 9 months and mice were examined for the following 20 days. At that time, DEN‑treated mice had multiple variably‑sized hepatic cell adenomas. Anti‑Wnt‑1 was particularly potent in suppressing the expression of critical elements of the Wnt/β‑catenin signaling pathway, such as β‑catenin and Frizzled‑1 receptor, however, not Dickkopf‑related protein 1. This effect co‑existed with the suppression of Cyclin D1, FOXM1, NF‑κΒ and c‑Jun commensurate with proliferation and apoptosis blockade in hepatocellular adenomas, and reduced Bcl‑2 and c‑Met in the serum of mice. Nonetheless, tumor size and multiplicity were found to be unaffected, suggesting that apoptosis may be equally important to proliferation in the context of counteracting DEN induced hepatocellular adenomas of mice.Keywords
This publication has 47 references indexed in Scilit:
- The Wnt/β-catenin pathway as a therapeutic target in human hepatocellular carcinomaClinics and Research in Hepatology and Gastroenterology, 2011
- Role of Wnt/β-catenin signaling in liver metabolism and cancerThe International Journal of Biochemistry & Cell Biology, 2011
- Beta-catenin signaling, liver regeneration and hepatocellular cancer: Sorting the good from the badSeminars in Cancer Biology, 2011
- Blockade of Wnt-1 signaling leads to anti-tumor effects in hepatocellular carcinoma cellsMolecular Cancer, 2009
- Blockade of Wnt Signaling Inhibits Angiogenesis and Tumor Growth in Hepatocellular CarcinomaCancer Research, 2009
- Experimental mouse models for hepatocellular carcinoma researchInternational Journal of Experimental Pathology, 2009
- Liver‐specific loss of β‐catenin blocks glutamine synthesis pathway activity and cytochrome p450 expression in mice†‡Hepatology, 2006
- Overview of the Molecular Biology of Hepatocellular Neoplasms and Hepatoblastomas of the Mouse LiverToxicologic Pathology, 2005
- Sustained hepatic expression of FoxM1B in transgenic mice has minimal effects on hepatocellular carcinoma development but increases cell proliferation rates in preneoplastic and early neoplastic lesionsOncogene, 2003
- Induction of apoptosis in mouse liver adenoma and carcinoma in vivo by transforming growth factor-?1Journal of Cancer Research and Clinical Oncology, 2003